Skip to content

logo

SEARCH icon
  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage
Search

SEARCH FOR AN ARTICLE

  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage

logo

icon

      HomeBiotech

      Biotech

      Celularity Provides Update Regarding Nasdaq Listing Compliance
      Biotech

      Celularity Provides Update Regarding Nasdaq Listing Compliance

      August 26, 2026
      Vector Science and Therapeutics Corp. Enters Into an Investor Relations Agreement and Grants Options
      Biotech

      Vector Science and Therapeutics Corp. Enters Into an Investor Relations Agreement and Grants Options

      August 26, 2026
      CAPR Investor Losses: Capricor Therapeutics Clinical Data Announcement and Corresponding 64% Stock Drop Trigger Securities Class Action for Investors
      Biotech

      CAPR Investor Losses: Capricor Therapeutics Clinical Data Announcement and Corresponding 64% Stock Drop Trigger Securities Class Action for Investors

      August 25, 2026
      First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis
      Biotech

      First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis

      August 24, 2026
      Jury Finds in Cytek’s Favor on Three of Four Asserted Claims; Company to Challenge Remaining Finding
      Biotech

      Jury Finds in Cytek’s Favor on Three of Four Asserted Claims; Company to Challenge Remaining Finding

      August 22, 2026
      Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
      Biotech

      Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

      August 22, 2026
      Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
      Biotech

      Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      August 21, 2026
      BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026
      Biotech

      BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026

      August 20, 2026
      Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline
      Biotech

      Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline

      August 20, 2026
      Edesa Biotech Announces Pricing of $25.0 Million Public Offering
      Biotech

      Edesa Biotech Announces Pricing of $25.0 Million Public Offering

      August 20, 2026
      « 1 … 9 10 11 12 13 … 212 »

       

      LATEST NEWS

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Stock Street News.

      I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

      Market Jar Media Inc. © 2026